Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KALM-B: Ketamine-assisted Psychotherapy (KAP) to Lessen Morbidity After Burn Injury
NCT07563296Phase 2Recruiting
- Start
- Aug 2026
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ketamine in acute stress disorder (ASD), post-traumatic stress disorder (PTSD). Started Aug 2026; status: recruiting.
02
Drugs
ketamine
03
Conditions
acute stress disorder (ASD)post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT07563296.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07563296.